Zdrowie i gospodarka · 11/07/2008

FDA Announces Draft Guidance for Electronic Drug Establishment Registration and Listing

The Food and Drug Administration (FDA) has released a draft guidance document that outlines the process for pharmaceutical companies to submit their drug establishment registration and listing information in electronic format, allowing the agency to efficiently review and archive the data.